rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2011-2-14
|
pubmed:abstractText |
The aim of the current study was to identify the antitumor activity of satraplatin in paired cisplatin (CDDP)-resistant oral squamous cell carcinoma (OSCC) cell line and its parental cell line.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1097-0347
|
pubmed:author |
pubmed-author:FujitaShigeyukiS,
pubmed-author:IwasawaShunichiroS,
pubmed-author:IyodaManabuM,
pubmed-author:KasamatsuAtsushiA,
pubmed-author:NakataniKenK,
pubmed-author:NegoroKenjiK,
pubmed-author:OgoshiKenjiK,
pubmed-author:SakumaKentaroK,
pubmed-author:ShiibaMasashiM,
pubmed-author:ShinozukaKeijiK,
pubmed-author:TakiguchiYuichiY,
pubmed-author:TanzawaHidekiH,
pubmed-author:UzawaKatsuhiroK,
pubmed-author:WadaTakeshiT,
pubmed-author:YamanoYukioY,
pubmed-author:YamatojiMasanobuM,
pubmed-author:YokoeHidetakaH
|
pubmed:copyrightInfo |
Copyright © 2010 Wiley Periodicals, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
309-17
|
pubmed:meshHeading |
pubmed-meshheading:20848452-Antineoplastic Agents,
pubmed-meshheading:20848452-Carcinoma, Squamous Cell,
pubmed-meshheading:20848452-Cell Proliferation,
pubmed-meshheading:20848452-Cisplatin,
pubmed-meshheading:20848452-Confidence Intervals,
pubmed-meshheading:20848452-Drug Resistance, Neoplasm,
pubmed-meshheading:20848452-Flow Cytometry,
pubmed-meshheading:20848452-Humans,
pubmed-meshheading:20848452-Mouth Neoplasms,
pubmed-meshheading:20848452-Organoplatinum Compounds,
pubmed-meshheading:20848452-RNA, Messenger,
pubmed-meshheading:20848452-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:20848452-Sensitivity and Specificity,
pubmed-meshheading:20848452-Statistics, Nonparametric,
pubmed-meshheading:20848452-Tumor Cells, Cultured
|
pubmed:year |
2011
|
pubmed:articleTitle |
Antitumor activity of satraplatin in cisplatin-resistant oral squamous cell carcinoma cells.
|
pubmed:affiliation |
Department of Clinical Molecular Biology, Graduate School of Medicine, Chiba University, Chiba, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|